One Patient’s Perspective on Clinical Research
Karen Sweeney, RN
Nancy Lecron, 68, was diagnosed with ovarian cancer in 2007. In July 2013, she enrolled in her third clinical trial for ovarian cancer at Abington Memorial Hospital (AMH) – a process she says is helping to manage her disease and give her more time.
Nancy successfully completed initial treatment for ovarian cancer six years ago, and remained in remission for two years. After a second course of treatment, she knew her cancer would return. Nancy wanted to do all she could to stay in remission for as long as possible. During that time, she traveled to Memorial Sloan-Kettering Cancer Center, New York, where specialists recommended she enroll in a clinical trial, which also was being conducted at Abington Memorial Hospital. Because Nancy could get the same treatment at AMH, which was closer to her home, she opted to make the 100-mile round trip between Birchrunville, PA, and Abington for care.
“Although I haven’t been in remission since 2011, with each clinical trial, I received the standard of care that already has been proven to be effective for my type and stage of ovarian cancer,” says Nancy. “At the same time, the trials presented the possibility that I might receive a new drug that has shown promise. Each experience was an opportunity to aid in the process of finding a cure.”